# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001636282-24-000021
Filing Date
2024-04-01
Accepted
2024-04-01 16:06:29
Documents
19
Period of Report
2024-05-13

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | syre-20240401.htm iXBRL | DEF 14A | 572031
6 |  | syre-20240401_g1.jpg | GRAPHIC | 24936
7 |  | syre-20240401_g2.jpg | GRAPHIC | 57992
8 |  | syre-20240401_g3.jpg | GRAPHIC | 59111
9 |  | syre-20240401_g4.jpg | GRAPHIC | 394534
10 |  | syre-20240401_g5.jpg | GRAPHIC | 109093
| Complete submission text file | 0001636282-24-000021.txt |  | 2744942

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | syre-20240401.xsd | EX-101.SCH | 4523
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | syre-20240401_def.xml | EX-101.DEF | 7227
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | syre-20240401_lab.xml | EX-101.LAB | 9103
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | syre-20240401_pre.xml | EX-101.PRE | 5824
22 | EXTRACTED XBRL INSTANCE DOCUMENT | syre-20240401_htm.xml | XML | 90702

Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37722 | Film No.: 24809164
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)